30/04/2016 12:55:57 1-888-992-3836 (toll free) Free Membership Login

Xenoport News (NASDAQ:XNPT)

DateTimeSource
Headline
04/26/20161:30PMBWXenoPort to Release First Quarter Financial Results on May 5, 2016
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its first quarter financial results on May 5, 2016 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A replay... More...>>
03/28/20168:30AMBWDr. Reddy’s Laboratories and XenoPort Enter Into a U.S. Licensing Agreement for XP23829
Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc. (NASDAQ: XNPT) announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage oral... More...>>
03/28/20161:40AMBWDr. Reddy’s Laboratories and XenoPort Enter into a U.S. Licensing Agreement for XP23829
Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc. (NASDAQ: XNPT) announced today that they have entered into a license agreement pursuant to which Dr. Reddy’s Laboratories will be granted exclusive U.S. rights for the development and commercialization of XenoPort’s clinical-stage oral... More...>>
03/07/20169:00AMBW#StopMakingExcuses Awareness Campaign for Restless Legs Syndrome Launches During Sleep Awareness Week 2016
Nearly 7 million Americans suffer from restless legs syndrome (RLS). For many patients suffering from moderate to severe symptoms, RLS is debilitating – disrupting sleep, influencing mood, and negatively affecting everyday life. Restless Legs Syndrome is a common and treatable neurologic disorder and the focus of a social... More...>>
03/01/20161:28PMBWXenoPort to Present at the Cowen and Company 36th Annual Health Care Conference
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2016 Cowen and Company 36th Annual Health Care Conference. The live presentation will occur at 5:40 a.m. Pacific Time (8:40 a.m. Eastern Time) on Wednesday, March 9, 2016. A replay of the presentation... More...>>
02/25/20164:05PMBWXenoPort Reports Fourth Quarter and Year-End 2015 Financial Results
Full-year 2015 net product sales of HORIZANT® (gabapentin enacarbil) Extended-Release Tablets increased 96% to $39.5 million Total HORIZANT prescribed tablet growth remained strong at 70% year over year* XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the fourth quarter and year ended December... More...>>
02/16/201610:00AMBWXenoPort to Release Fourth Quarter and Year-End Financial Results on February 25, 2016
XenoPort, Inc. (NASDAQ:XNPT) announced today that it will release its fourth quarter and year-end financial results on February 25, 2016 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business... More...>>
11/04/20154:05PMBWXenoPort Reports Third Quarter Financial Results
HORIZANT Net Product Sales Increase 94% Over Third Quarter 2014 XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2015. Net product sales for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets nearly doubled to $11.0 million for the third quarter... More...>>
10/29/20152:19PMBWXenoPort to Present at the Credit Suisse Healthcare Conference
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2015 Credit Suisse Healthcare Conference in Phoenix, Arizona. The live presentation will occur at 9:30 a.m. Pacific Time (10:30 a.m. Mountain Time) on Wednesday, November 11, 2015. A replay of the... More...>>
10/27/201510:00AMBWXenoPort to Release Third Quarter Financial Results on November 4
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its third quarter financial results on November 4, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A... More...>>
10/01/20154:05PMBWXenoPort Announces Plan to Focus on its Growing HORIZANT Bus. & Names Vincent J. Angotti Chief Executive Officer & Director
XenoPort, Inc. (Nasdaq: XNPT) announced today a strategic shift to focus on and maximize the value of its commercial product, HORIZANT® (gabapentin enacarbil) Extended Release Tablets. As part of this shift, XenoPort will discontinue development of XP23829 on its own and seek to partner this and other high potential development... More...>>
09/15/20159:48AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to trade actively in Tuesday's session are Gray Television Inc. (GTN), XenoPort Inc. (XNPT) and Cheniere Energy Inc. (LNG). Gray Television continues to be an active acquirer, announcing a deal on Monday to buy Schurz Communications Inc.'s television and radio stations... More...>>
09/15/20156:30AMBWXenoPort Announces Positive Phase 2 Study Results for XP23829 as a Potential Treatment for Patients with Psoriasis
Efficacy observed with both 800 mg once-daily and 400 mg twice-daily XP23829 dosing XP23829 safe and generally well-tolerated with low incidence of flushing similar to placebo Low incidence/severity of lymphopenia seen with XP23829 First clinical demonstration of efficacy of a MMF prodrug other than DMF XenoPort, Inc... More...>>
09/04/201510:00AMBWXenoPort to Present at the Morgan Stanley Global Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time) on Wednesday, September 16, 2015. A replay of the presentation will... More...>>
09/02/201510:30AMBWXenoPort to Present at the 2015 Wells Fargo Healthcare Conference
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2015 Wells Fargo Healthcare Conference. The live presentation will occur at 10:10 a.m. Pacific Time (1:10 p.m. Eastern Time) on Wednesday, September 9, 2015. A replay of the presentation will also... More...>>
08/05/20154:05PMBWXenoPort Reports Second Quarter Financial Results
HORIZANT Net Product Sales Increased 67% Over Second Quarter 2014 XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the second quarter and six months ended June 30, 2015. Total revenues for the second quarter were $8.6 million, compared to $5.3 million for the same period in 2014. Net loss for the second... More...>>
07/27/201510:00AMBWXenoPort to Release Second Quarter Financial Results on August 5, 2015
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its second quarter financial results on August 5, 2015 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:00 p.m. Eastern Time that same day to provide a summary of its financial results and general business updates. A... More...>>
06/25/20158:30AMBWXenoPort Announces Initiation by NIAAA of Clinical Trial of HORIZANT in Patients with Alcohol Use Disorder
XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that the NIAAA has initiated a clinical trial of HORIZANT® (gabapentin enacarbil) Extended-Release Tablets as a potential treatment for alcohol use disorder (AUD). “This multi-site, well-controlled clinical... More...>>
06/08/20158:30AMBWHORIZANT (gabapentin enacarbil) Included in New Expert Recommendations on Prevention and Treatment of RLS Augmentation
XenoPort, Inc. (Nasdaq:XNPT) reported today that new expert recommendations for the prevention and treatment of augmentation in patients suffering from restless legs syndrome (RLS) list gabapentin enacarbil as a first-line therapy with a lower risk of developing augmentation. In addition, gabapentin enacarbil is listed... More...>>
06/02/20158:30AMBWXenoPort to Present New Pooled Data Analyses on HORIZANT (gabapentin enacarbil) at the 2015 SLEEP Annual Meeting
XenoPort, Inc. (Nasdaq: XNPT) announced today that pooled data analyses for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, will be presented at the upcoming 29th Associated Professional Sleep Societies (APSS) annual SLEEP meeting in Seattle. The presentations include: Association Between Pain and Symptoms... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V:us D:20160430 16:55:59